Setting priorities for the adoption of health technologies on a national level — the Israeli experience
The rapid development of new and expensive health technologies together with the limited resources available for the health care system, makes priority setting or rationing inevitable. The Israeli Health Insurance Law, enacted in 1995, determined a basic list of health services to be provided to all...
Gespeichert in:
Veröffentlicht in: | Health policy (Amsterdam) 2000-12, Vol.54 (3), p.169-185 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 185 |
---|---|
container_issue | 3 |
container_start_page | 169 |
container_title | Health policy (Amsterdam) |
container_volume | 54 |
creator | Shani, Segev Siebzehner, Miriam Ines Luxenburg, Osnat Shemer, Joshua |
description | The rapid development of new and expensive health technologies together with the limited resources available for the health care system, makes priority setting or rationing inevitable. The Israeli Health Insurance Law, enacted in 1995, determined a basic list of health services to be provided to all residents by public funding. Although the Israeli health care system has reached a high standard of medical care as expressed by parameters such as long life expectancy and low infant mortality, the social and professional demand for new and expensive health technologies is increasing. Towards the fiscal year of 1999, the Medical Technologies Administration of the Ministry of Health recommended a list of new technologies to be added to the list of health services. The Ministry of Finance allocated that year US$ 35 million for this purpose, while a rough assessment found that there are new important technologies to be added at a cost of more than US$ 350 million. The Medical Technologies Administration took a systematic approach of health technology assessment — ad-hoc teams were established for evaluating clinical safety, efficacy and effectiveness, conducting needs assessment and cost-effectiveness descriptions. Assessment of the data was based on evidence-based medicine. A set of criteria was determined in order to enable the prioritizing of the assessed new technologies. This procedure led to a list of technologies suggested for inclusion. The Minister of Health appointed a public committee whose purpose was to decide the technologies to be added to the list of health services. The committee, made up of representatives from the government, the sick-funds and the public, had to evaluate each technology, based on the analysis submitted to the committee, taking into consideration clinical, economic, social, ethical and legal aspects according to predefined criteria. The thorough work of the Medical Technologies Administration enabled the committee to adopt its recommended list with minor changes within a limited timeframe. In conclusion, we propose a practical and pragmatic model for the inclusion of new health technologies at a national level, based on health technology assessment and explicit priority setting. |
doi_str_mv | 10.1016/S0168-8510(00)00109-3 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72543086</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168851000001093</els_id><sourcerecordid>72543086</sourcerecordid><originalsourceid>FETCH-LOGICAL-c542t-33b736deae29c15ad319821e6572db4e57a4c7de5e9ae8bbba41b4c01d3a59b13</originalsourceid><addsrcrecordid>eNqFkc9u1DAQxi0EotvCI4B8QnAIeOI4cU4IVfwpqsShcLYce7Yx8sbB9q7ojYfgCXmSOrurclzJ38zBv2809kfIC2BvgUH77qYUWUkB7DVjbxgD1lf8EVmB7OqqZaJ5TFYPyBk5T-knY6zjvH1KzgBANJ3sVsTdYM5uuqVzdCG67DDRdYg0j0i1DXN2YaJhTUfUPo80oxmn4MPtwpUbTSe9INpTjzv09N-fv3vvVYoavaP4e8bocDL4jDxZa5_w-bFfkB-fPn6__FJdf_t8dfnhujKiqXPF-dDx1qLGujcgtOXQyxqwFV1thwZFpxvTWRTYa5TDMOgGhsYwsFyLfgB-QV4d5s4x_NpiymrjkkHv9YRhm1RXi4Yz2Z4ERS8LB6dB3jPGpagLKA6giSGliGtVfnWj450CppbU1D41tUSi2HJKaooX39eDL-KM5sGEiCPOwTu1U-VxTSl3RXXJsTRXxIvmImh7BVKoMW_KsJfHbbfDBu3_FY6ZF-D9AcCSws5hVMnsE7IuosnKBndi33uGysHD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>39003852</pqid></control><display><type>article</type><title>Setting priorities for the adoption of health technologies on a national level — the Israeli experience</title><source>MEDLINE</source><source>RePEc</source><source>Elsevier ScienceDirect Journals Complete</source><source>PAIS Index</source><creator>Shani, Segev ; Siebzehner, Miriam Ines ; Luxenburg, Osnat ; Shemer, Joshua</creator><creatorcontrib>Shani, Segev ; Siebzehner, Miriam Ines ; Luxenburg, Osnat ; Shemer, Joshua</creatorcontrib><description>The rapid development of new and expensive health technologies together with the limited resources available for the health care system, makes priority setting or rationing inevitable. The Israeli Health Insurance Law, enacted in 1995, determined a basic list of health services to be provided to all residents by public funding. Although the Israeli health care system has reached a high standard of medical care as expressed by parameters such as long life expectancy and low infant mortality, the social and professional demand for new and expensive health technologies is increasing. Towards the fiscal year of 1999, the Medical Technologies Administration of the Ministry of Health recommended a list of new technologies to be added to the list of health services. The Ministry of Finance allocated that year US$ 35 million for this purpose, while a rough assessment found that there are new important technologies to be added at a cost of more than US$ 350 million. The Medical Technologies Administration took a systematic approach of health technology assessment — ad-hoc teams were established for evaluating clinical safety, efficacy and effectiveness, conducting needs assessment and cost-effectiveness descriptions. Assessment of the data was based on evidence-based medicine. A set of criteria was determined in order to enable the prioritizing of the assessed new technologies. This procedure led to a list of technologies suggested for inclusion. The Minister of Health appointed a public committee whose purpose was to decide the technologies to be added to the list of health services. The committee, made up of representatives from the government, the sick-funds and the public, had to evaluate each technology, based on the analysis submitted to the committee, taking into consideration clinical, economic, social, ethical and legal aspects according to predefined criteria. The thorough work of the Medical Technologies Administration enabled the committee to adopt its recommended list with minor changes within a limited timeframe. In conclusion, we propose a practical and pragmatic model for the inclusion of new health technologies at a national level, based on health technology assessment and explicit priority setting.</description><identifier>ISSN: 0168-8510</identifier><identifier>EISSN: 1872-6054</identifier><identifier>DOI: 10.1016/S0168-8510(00)00109-3</identifier><identifier>PMID: 11154787</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Costs ; Decision Making, Organizational ; Decision-making ; Diffusion of Innovation ; Drugs ; Finance ; Health ; Health administration ; Health care ; Health care decision-making ; Health economics ; Health planning ; Health Policy ; Health Priorities ; Health services ; Health technology assessment ; Humans ; Israel ; Medical care ; Medical service ; Medical technology ; Priority setting ; Rationing ; Social policy ; Technology ; Technology Assessment, Biomedical - organization & administration</subject><ispartof>Health policy (Amsterdam), 2000-12, Vol.54 (3), p.169-185</ispartof><rights>2000 Elsevier Science Ireland Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c542t-33b736deae29c15ad319821e6572db4e57a4c7de5e9ae8bbba41b4c01d3a59b13</citedby><cites>FETCH-LOGICAL-c542t-33b736deae29c15ad319821e6572db4e57a4c7de5e9ae8bbba41b4c01d3a59b13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0168851000001093$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,3994,27842,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11154787$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://econpapers.repec.org/article/eeehepoli/v_3a54_3ay_3a2000_3ai_3a3_3ap_3a169-185.htm$$DView record in RePEc$$Hfree_for_read</backlink></links><search><creatorcontrib>Shani, Segev</creatorcontrib><creatorcontrib>Siebzehner, Miriam Ines</creatorcontrib><creatorcontrib>Luxenburg, Osnat</creatorcontrib><creatorcontrib>Shemer, Joshua</creatorcontrib><title>Setting priorities for the adoption of health technologies on a national level — the Israeli experience</title><title>Health policy (Amsterdam)</title><addtitle>Health Policy</addtitle><description>The rapid development of new and expensive health technologies together with the limited resources available for the health care system, makes priority setting or rationing inevitable. The Israeli Health Insurance Law, enacted in 1995, determined a basic list of health services to be provided to all residents by public funding. Although the Israeli health care system has reached a high standard of medical care as expressed by parameters such as long life expectancy and low infant mortality, the social and professional demand for new and expensive health technologies is increasing. Towards the fiscal year of 1999, the Medical Technologies Administration of the Ministry of Health recommended a list of new technologies to be added to the list of health services. The Ministry of Finance allocated that year US$ 35 million for this purpose, while a rough assessment found that there are new important technologies to be added at a cost of more than US$ 350 million. The Medical Technologies Administration took a systematic approach of health technology assessment — ad-hoc teams were established for evaluating clinical safety, efficacy and effectiveness, conducting needs assessment and cost-effectiveness descriptions. Assessment of the data was based on evidence-based medicine. A set of criteria was determined in order to enable the prioritizing of the assessed new technologies. This procedure led to a list of technologies suggested for inclusion. The Minister of Health appointed a public committee whose purpose was to decide the technologies to be added to the list of health services. The committee, made up of representatives from the government, the sick-funds and the public, had to evaluate each technology, based on the analysis submitted to the committee, taking into consideration clinical, economic, social, ethical and legal aspects according to predefined criteria. The thorough work of the Medical Technologies Administration enabled the committee to adopt its recommended list with minor changes within a limited timeframe. In conclusion, we propose a practical and pragmatic model for the inclusion of new health technologies at a national level, based on health technology assessment and explicit priority setting.</description><subject>Costs</subject><subject>Decision Making, Organizational</subject><subject>Decision-making</subject><subject>Diffusion of Innovation</subject><subject>Drugs</subject><subject>Finance</subject><subject>Health</subject><subject>Health administration</subject><subject>Health care</subject><subject>Health care decision-making</subject><subject>Health economics</subject><subject>Health planning</subject><subject>Health Policy</subject><subject>Health Priorities</subject><subject>Health services</subject><subject>Health technology assessment</subject><subject>Humans</subject><subject>Israel</subject><subject>Medical care</subject><subject>Medical service</subject><subject>Medical technology</subject><subject>Priority setting</subject><subject>Rationing</subject><subject>Social policy</subject><subject>Technology</subject><subject>Technology Assessment, Biomedical - organization & administration</subject><issn>0168-8510</issn><issn>1872-6054</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>X2L</sourceid><sourceid>7TQ</sourceid><recordid>eNqFkc9u1DAQxi0EotvCI4B8QnAIeOI4cU4IVfwpqsShcLYce7Yx8sbB9q7ojYfgCXmSOrurclzJ38zBv2809kfIC2BvgUH77qYUWUkB7DVjbxgD1lf8EVmB7OqqZaJ5TFYPyBk5T-knY6zjvH1KzgBANJ3sVsTdYM5uuqVzdCG67DDRdYg0j0i1DXN2YaJhTUfUPo80oxmn4MPtwpUbTSe9INpTjzv09N-fv3vvVYoavaP4e8bocDL4jDxZa5_w-bFfkB-fPn6__FJdf_t8dfnhujKiqXPF-dDx1qLGujcgtOXQyxqwFV1thwZFpxvTWRTYa5TDMOgGhsYwsFyLfgB-QV4d5s4x_NpiymrjkkHv9YRhm1RXi4Yz2Z4ERS8LB6dB3jPGpagLKA6giSGliGtVfnWj450CppbU1D41tUSi2HJKaooX39eDL-KM5sGEiCPOwTu1U-VxTSl3RXXJsTRXxIvmImh7BVKoMW_KsJfHbbfDBu3_FY6ZF-D9AcCSws5hVMnsE7IuosnKBndi33uGysHD</recordid><startdate>20001201</startdate><enddate>20001201</enddate><creator>Shani, Segev</creator><creator>Siebzehner, Miriam Ines</creator><creator>Luxenburg, Osnat</creator><creator>Shemer, Joshua</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>DKI</scope><scope>X2L</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8BJ</scope><scope>FQK</scope><scope>JBE</scope><scope>7TQ</scope><scope>DHY</scope><scope>DON</scope><scope>7X8</scope></search><sort><creationdate>20001201</creationdate><title>Setting priorities for the adoption of health technologies on a national level — the Israeli experience</title><author>Shani, Segev ; Siebzehner, Miriam Ines ; Luxenburg, Osnat ; Shemer, Joshua</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c542t-33b736deae29c15ad319821e6572db4e57a4c7de5e9ae8bbba41b4c01d3a59b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Costs</topic><topic>Decision Making, Organizational</topic><topic>Decision-making</topic><topic>Diffusion of Innovation</topic><topic>Drugs</topic><topic>Finance</topic><topic>Health</topic><topic>Health administration</topic><topic>Health care</topic><topic>Health care decision-making</topic><topic>Health economics</topic><topic>Health planning</topic><topic>Health Policy</topic><topic>Health Priorities</topic><topic>Health services</topic><topic>Health technology assessment</topic><topic>Humans</topic><topic>Israel</topic><topic>Medical care</topic><topic>Medical service</topic><topic>Medical technology</topic><topic>Priority setting</topic><topic>Rationing</topic><topic>Social policy</topic><topic>Technology</topic><topic>Technology Assessment, Biomedical - organization & administration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shani, Segev</creatorcontrib><creatorcontrib>Siebzehner, Miriam Ines</creatorcontrib><creatorcontrib>Luxenburg, Osnat</creatorcontrib><creatorcontrib>Shemer, Joshua</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>RePEc IDEAS</collection><collection>RePEc</collection><collection>CrossRef</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>International Bibliography of the Social Sciences</collection><collection>International Bibliography of the Social Sciences</collection><collection>PAIS Index</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>MEDLINE - Academic</collection><jtitle>Health policy (Amsterdam)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shani, Segev</au><au>Siebzehner, Miriam Ines</au><au>Luxenburg, Osnat</au><au>Shemer, Joshua</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Setting priorities for the adoption of health technologies on a national level — the Israeli experience</atitle><jtitle>Health policy (Amsterdam)</jtitle><addtitle>Health Policy</addtitle><date>2000-12-01</date><risdate>2000</risdate><volume>54</volume><issue>3</issue><spage>169</spage><epage>185</epage><pages>169-185</pages><issn>0168-8510</issn><eissn>1872-6054</eissn><abstract>The rapid development of new and expensive health technologies together with the limited resources available for the health care system, makes priority setting or rationing inevitable. The Israeli Health Insurance Law, enacted in 1995, determined a basic list of health services to be provided to all residents by public funding. Although the Israeli health care system has reached a high standard of medical care as expressed by parameters such as long life expectancy and low infant mortality, the social and professional demand for new and expensive health technologies is increasing. Towards the fiscal year of 1999, the Medical Technologies Administration of the Ministry of Health recommended a list of new technologies to be added to the list of health services. The Ministry of Finance allocated that year US$ 35 million for this purpose, while a rough assessment found that there are new important technologies to be added at a cost of more than US$ 350 million. The Medical Technologies Administration took a systematic approach of health technology assessment — ad-hoc teams were established for evaluating clinical safety, efficacy and effectiveness, conducting needs assessment and cost-effectiveness descriptions. Assessment of the data was based on evidence-based medicine. A set of criteria was determined in order to enable the prioritizing of the assessed new technologies. This procedure led to a list of technologies suggested for inclusion. The Minister of Health appointed a public committee whose purpose was to decide the technologies to be added to the list of health services. The committee, made up of representatives from the government, the sick-funds and the public, had to evaluate each technology, based on the analysis submitted to the committee, taking into consideration clinical, economic, social, ethical and legal aspects according to predefined criteria. The thorough work of the Medical Technologies Administration enabled the committee to adopt its recommended list with minor changes within a limited timeframe. In conclusion, we propose a practical and pragmatic model for the inclusion of new health technologies at a national level, based on health technology assessment and explicit priority setting.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>11154787</pmid><doi>10.1016/S0168-8510(00)00109-3</doi><tpages>17</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0168-8510 |
ispartof | Health policy (Amsterdam), 2000-12, Vol.54 (3), p.169-185 |
issn | 0168-8510 1872-6054 |
language | eng |
recordid | cdi_proquest_miscellaneous_72543086 |
source | MEDLINE; RePEc; Elsevier ScienceDirect Journals Complete; PAIS Index |
subjects | Costs Decision Making, Organizational Decision-making Diffusion of Innovation Drugs Finance Health Health administration Health care Health care decision-making Health economics Health planning Health Policy Health Priorities Health services Health technology assessment Humans Israel Medical care Medical service Medical technology Priority setting Rationing Social policy Technology Technology Assessment, Biomedical - organization & administration |
title | Setting priorities for the adoption of health technologies on a national level — the Israeli experience |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T11%3A39%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Setting%20priorities%20for%20the%20adoption%20of%20health%20technologies%20on%20a%20national%20level%20%E2%80%94%20the%20Israeli%20experience&rft.jtitle=Health%20policy%20(Amsterdam)&rft.au=Shani,%20Segev&rft.date=2000-12-01&rft.volume=54&rft.issue=3&rft.spage=169&rft.epage=185&rft.pages=169-185&rft.issn=0168-8510&rft.eissn=1872-6054&rft_id=info:doi/10.1016/S0168-8510(00)00109-3&rft_dat=%3Cproquest_cross%3E72543086%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=39003852&rft_id=info:pmid/11154787&rft_els_id=S0168851000001093&rfr_iscdi=true |